A Study of C-CAR039 Treatment in Subjects With r/r NHL SubjectsNon-Hodgkin's Lymphoma

NCT04696432 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Non-Hodgkin's B-cell Lymphoma

Interventions

BIOLOGICAL: Prizloncabtagene autoleucel

Sponsor

Tianjin Medical University Cancer Institute and Hospital

Collaborators

[object Object]